Jamie Privratsky

Jamie Privratsky


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2014 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
JPJamie Privratsky
Jamie Privratsky
PNPeter J. Newman
Peter J. Newman

1 July 2010 in Life Sciences
Verified
Journal Article
Closed access
JPJamie Privratsky
Jamie Privratsky
DNDebra K. Newman
Debra K. Newman
PNPeter J. Newman
Peter J. Newman

1 August 2003 in Hypertension
Verified
Journal Article
Closed access
JPJamie Privratsky
Jamie Privratsky
LWLoren E. Wold
Loren E. Wold
JSJames R. Sowers
James R. Sowers
Mark QuinnMark Quinn
Mark Quinn
JRJun Ren
Jun Ren
Enhanced tissue angiotensin (Ang) II levels have been reported in diabetes and might lead to cardiac dysfunction through oxidative stress. This study examined the effect of blocking the Ang II type 1 (AT 1 ) receptor on high glucose–induced cardiac contractile dysfunction. Rat ventricular myocytes were maintained in normal- (NG, 5.5 mmol/L) or high- (HG, 25.5 mmol/L) glucose medium for 24 hours. Mechanical and intracellular Ca 2+ properties were assessed as peak shortening (PS), time to PS (TPS), time to 90% relengthening (TR 90 ), maximal velocity of shortening/relengthening (± dL / dt ), and intracellular Ca 2+ decay (τ). HG myocytes exhibited normal PS; decreased ± dL / dt ; and prolonged TPS, TR 90 , and τ. Interestingly, the HG-induced abnormalities were prevented with the AT 1 blocker L-158,809 (10 to 1000 nmol/L) but not the Janus kinase-2 (JAK2) inhibitor AG-490 (10 to 100 μmol/L). The only effect of AT 1 blockade on NG myocytes was enhanced PS at 1000 nmol/L. AT 1 antagonist-elicited cardiac protection against HG was nullified by the NADPH oxidase activator sodium dodecyl sulfate (80 μmol/L) and mimicked by the NADPH oxidase inhibitors diphenyleneiodonium (10 μmol/L) or apocynin (100 μmol/L). Western blot analysis confirmed that the protein abundance of NADPH oxidase subunit p47 phox and the AT 1 but not the AT 2 receptor was enhanced in HG myocytes. In addition, the HG-induced increase of p47 phox was prevented by L-158,809. Enhanced reactive oxygen species production observed in HG myocytes was prevented by AT 1 blockade or NADPH oxidase inhibition. Collectively, our data suggest that local Ang II, acting via AT 1 receptor–mediated NADPH oxidase activation, is involved in hyperglycemia-induced cardiomyocyte dysfunction, which might play a role in diabetic cardiomyopathy.

1 May 2011 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
JPJamie Privratsky
Jamie Privratsky
CPCathy M. Paddock
Cathy M. Paddock
OFOliver Florey
Oliver Florey
DNDebra K. Newman
Debra K. Newman
WMWilliam A. Muller
William A. Muller
PNPeter J. Newman
Peter J. Newman
PECAM-1 (CD31) is a cellular adhesion and signaling receptor that is highly expressed at endothelial cell–cell junctions in confluent vascular beds. Previous studies have implicated PECAM-1 in the maintenance of vascular barrier integrity; however, the mechanisms behind PECAM-1-mediated barrier protection are still poorly understood. The goal of the present study, therefore, was to examine the pertinent biological properties of PECAM-1 (i.e. adhesion and/or signaling) that allow it to support barrier integrity. We found that, compared with PECAM-1-deficient endothelial cells, PECAM-1-expressing endothelial cell monolayers exhibit increased steady-state barrier function, as well as more rapid restoration of barrier integrity following thrombin-induced perturbation of the endothelial cell monolayer. The majority of PECAM-1-mediated barrier protection was found to be due to the ability of PECAM-1 to interact homophilically and become localized to cell–cell junctions, because a homophilic binding-crippled mutant form of PECAM-1 was unable to support efficient barrier function when re-expressed in cells. By contrast, cells expressing PECAM-1 variants lacking residues known to be involved in PECAM-1-mediated signal transduction exhibited normal to near-normal barrier integrity. Taken together, these studies suggest that PECAM-1–PECAM-1 homophilic interactions are more important than its signaling function for maintaining the integrity of endothelial cell junctions.

1 April 2006 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
LWLoren E. Wold
Loren E. Wold
ACAsli F. Ceylan-Isik
Asli F. Ceylan-Isik
CFCindy X. Fang
Cindy X. Fang
XYXiaoping Yang
Xiaoping Yang
SLShi-Yan Li
Shi-Yan Li
JRJun Ren
Jun Ren

1 July 2008 in Critical Care Medicine
Verified
Journal Article
Closed access
JRJun Ren
Jun Ren
JPJamie Privratsky
Jamie Privratsky
XYXiaoping Yang
Xiaoping Yang
FDFeng Dong
Feng Dong
ECEdward C. Carlson
Edward C. Carlson
Objective: Antioxidant therapy has shown some promise in critical care medicine in which glutathione depletion and heart failure are often seen in critically ill patients. This study was designed to examine the impact of glutathione depletion and the free radical scavenger, metallothionein (MT), on cardiac function. Design: Friend virus B and MT transgenic mice were given the glutathione synthase inhibitor buthionine sulfoximine (buthionine sulfoximine [BSO], 30 mmol/L) in drinking water for 2 wks. Measurements: Echocardiographic and cardiomyocyte functions were evaluated, including myocardial geometry, fraction shortening, peak shortening, time-to-90% relengthening (TR90), maximal velocity of shortening/relengthening (±dL/dt), intracellular Ca2+ rise, sarcoplasmic reticulum Ca2+ release, and intracellular Ca2+ decay rate. Sacro (endo)plasmic reticulum Ca2+-ATPase function was evaluated by 45Ca uptake. Highly reactive oxygen species, caspase-3, and aconitase activity were detected by fluorescent probe and colorimetric assays. Main Result: BSO elicited lipid peroxidation, protein carbonyl formation, mitochondrial damage, and apoptosis. BSO also reduced wall thickness, enhanced end systolic diameter, depressed fraction shortening, peak shortening, ±dL/dt, sarcoplasmic reticulum Ca2+ release, 45Ca uptake, and intracellular Ca2+ decay, leading to prolonged TR90. BSO-induced mitochondrial loss and myofilament aberration. MT transgene itself had little effect on myocardial mechanics and ultrastructure. However, it alleviated BSO-induced myocardial functional, morphologic, and carbonyl changes. Western blot analysis showed reduced expression of sacro (endo)plasmic reticulum Ca2+-ATPase2a, Bcl-2 and phosphorylated GSK-3β, enhanced calreticulin, Bax, p53, myosin heavy chain-β isozyme switch, and IκB phosphorylation in FVB-BSO mice, all of which with the exception of p53 were nullified by MT. Conclusion: Our findings suggest a pathologic role of glutathione depletion in cardiac dysfunction and the therapeutic potential of antioxidants.